ABBV
40
5
AAP
26
5
FE
34
4
MSI
52
3
ED
39
8
GILD
55
5
TAP
57
6
UA
48
6
VNO
46
6
ROK
46
3
OMC
37
2
ROST
60
3
UHS
50
4
CA
19
6
MRK
25
2
PNW
55
3
THC
52
9
DIS
70
2
SIG
52
5
IR
46
3
ABBV
40
5
AAP
26
5
FE
34
4
MSI
52
3
ED
39
8
GILD
55
5
TAP
57
6
UA
48
6
VNO
46
6
ROK
46
3
OMC
37
2
ROST
60
3
UHS
50
4
CA
19
6
MRK
25
2
PNW
55
3
THC
52
9
DIS
70
2
SIG
52
5
IR
46
3
Financhill
Back

BioCardia Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
34

BCDA
BioCardia

Last Price:
$1.97
Seasonality Move:
-10.6%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
$0.53
Seasonality Move:
-0.66%
Sell
34
BioCardia (BCDA) is a Sell

Is BioCardia a Buy, Sell or Hold?

  • The current BioCardia [BCDA] share price is $1.97. The Score for BCDA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • BCDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BCDA Stock Price Chart

What is BioCardia's stock price today?

  • The BioCardia share price today is $1.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCDA is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

BCDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 41.08 Sell
Chaikin Money Flow: -953 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2 - 2.28) Sell
Bollinger Bands (100): (2.16 - 2.92) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39.44 Sell
Chaikin Money Flow: 514099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 0.67) Sell
Bollinger Bands (100): (0.49 - 0.69) Sell

BCDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.05 Sell
20-day SMA: 2.17 Sell
50-day SMA: 2.3 Sell
200-day SMA: 3.64 Sell
8-day EMA: 2.04 Sell
20-day EMA: 2.13 Sell
50-day EMA: 2.3 Sell
200-day EMA: 4.35 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.54 Sell
20-day SMA: 0.57 Sell
50-day SMA: 0.63 Sell
200-day SMA: 1.88 Sell
8-day EMA: 0.54 Sell
20-day EMA: 0.57 Sell
50-day EMA: 0.64 Sell
200-day EMA: 4.7 Sell

BioCardia Earnings Growth & BCDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.38 per share, and an increase next year of $2.30 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

BioCardia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):